Literature DB >> 22907262

Genetics: mutations in mTOR pathway linked to megalencephaly syndromes.

Pasquale Striano, Federico Zara.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22907262     DOI: 10.1038/nrneurol.2012.178

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly.

Authors:  Jeong Ho Lee; My Huynh; Jennifer L Silhavy; Sangwoo Kim; Tracy Dixon-Salazar; Andrew Heiberg; Eric Scott; Vineet Bafna; Kiley J Hill; Adrienne Collazo; Vincent Funari; Carsten Russ; Stacey B Gabriel; Gary W Mathern; Joseph G Gleeson
Journal:  Nat Genet       Date:  2012-06-24       Impact factor: 38.330

Review 2.  Targeting PI3 kinase/AKT/mTOR signaling in cancer.

Authors:  Karen Sheppard; Kathryn M Kinross; Benjamin Solomon; Richard B Pearson; Wayne A Phillips
Journal:  Crit Rev Oncog       Date:  2012

Review 3.  Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis.

Authors:  David Neal Franz
Journal:  Expert Rev Anticancer Ther       Date:  2011-08       Impact factor: 4.512

Review 4.  Epidemiology of hemimegalencephaly: a case series and review.

Authors:  Brad T Tinkle; Elizabeth K Schorry; David N Franz; Kerry R Crone; Howard M Saal
Journal:  Am J Med Genet A       Date:  2005-12-15       Impact factor: 2.802

5.  Somatic activation of AKT3 causes hemispheric developmental brain malformations.

Authors:  Annapurna Poduri; Gilad D Evrony; Xuyu Cai; Princess Christina Elhosary; Rameen Beroukhim; Maria K Lehtinen; L Benjamin Hills; Erin L Heinzen; Anthony Hill; R Sean Hill; Brenda J Barry; Blaise F D Bourgeois; James J Riviello; A James Barkovich; Peter M Black; Keith L Ligon; Christopher A Walsh
Journal:  Neuron       Date:  2012-04-12       Impact factor: 17.173

6.  A mosaic activating mutation in AKT1 associated with the Proteus syndrome.

Authors:  Marjorie J Lindhurst; Julie C Sapp; Jamie K Teer; Jennifer J Johnston; Erin M Finn; Kathryn Peters; Joyce Turner; Jennifer L Cannons; David Bick; Laurel Blakemore; Catherine Blumhorst; Knut Brockmann; Peter Calder; Natasha Cherman; Matthew A Deardorff; David B Everman; Gretchen Golas; Robert M Greenstein; B Maya Kato; Kim M Keppler-Noreuil; Sergei A Kuznetsov; Richard T Miyamoto; Kurt Newman; David Ng; Kevin O'Brien; Steven Rothenberg; Douglas J Schwartzentruber; Virender Singhal; Roberto Tirabosco; Joseph Upton; Shlomo Wientroub; Elaine H Zackai; Kimberly Hoag; Tracey Whitewood-Neal; Pamela G Robey; Pamela L Schwartzberg; Thomas N Darling; Laura L Tosi; James C Mullikin; Leslie G Biesecker
Journal:  N Engl J Med       Date:  2011-07-27       Impact factor: 91.245

7.  Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis.

Authors:  Ghayda M Mirzaa; Robert L Conway; Karen W Gripp; Tally Lerman-Sagie; Dawn H Siegel; Linda S deVries; Dorit Lev; Nancy Kramer; Elizabeth Hopkins; John M Graham; William B Dobyns
Journal:  Am J Med Genet A       Date:  2012-01-06       Impact factor: 2.802

Review 8.  Macrocephaly syndromes.

Authors:  Ann Haskins Olney
Journal:  Semin Pediatr Neurol       Date:  2007-09       Impact factor: 1.636

Review 9.  Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies.

Authors:  Michael Wong
Journal:  Epilepsia       Date:  2009-10-08       Impact factor: 5.864

10.  De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes.

Authors:  Jean-Baptiste Rivière; Ghayda M Mirzaa; Brian J O'Roak; Margaret Beddaoui; Diana Alcantara; Robert L Conway; Judith St-Onge; Jeremy A Schwartzentruber; Karen W Gripp; Sarah M Nikkel; Thea Worthylake; Christopher T Sullivan; Thomas R Ward; Hailly E Butler; Nancy A Kramer; Beate Albrecht; Christine M Armour; Linlea Armstrong; Oana Caluseriu; Cheryl Cytrynbaum; Beth A Drolet; A Micheil Innes; Julie L Lauzon; Angela E Lin; Grazia M S Mancini; Wendy S Meschino; James D Reggin; Anand K Saggar; Tally Lerman-Sagie; Gökhan Uyanik; Rosanna Weksberg; Birgit Zirn; Chandree L Beaulieu; Jacek Majewski; Dennis E Bulman; Mark O'Driscoll; Jay Shendure; John M Graham; Kym M Boycott; William B Dobyns
Journal:  Nat Genet       Date:  2012-06-24       Impact factor: 38.330

  10 in total
  7 in total

1.  NPAS1 represses the generation of specific subtypes of cortical interneurons.

Authors:  Amelia Stanco; Ramón Pla; Daniel Vogt; Yiran Chen; Shyamali Mandal; Jamie Walker; Robert F Hunt; Susan Lindtner; Carolyn A Erdman; Andrew A Pieper; Steven P Hamilton; Duan Xu; Scott C Baraban; John L R Rubenstein
Journal:  Neuron       Date:  2014-11-20       Impact factor: 17.173

Review 2.  Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction.

Authors:  Ethan M Goldberg; Douglas A Coulter
Journal:  Nat Rev Neurosci       Date:  2013-04-18       Impact factor: 34.870

Review 3.  Hydranencephaly: cerebral spinal fluid instead of cerebral mantles.

Authors:  Piero Pavone; Andrea D Praticò; Giovanna Vitaliti; Martino Ruggieri; Renata Rizzo; Enrico Parano; Lorenzo Pavone; Giuseppe Pero; Raffaele Falsaperla
Journal:  Ital J Pediatr       Date:  2014-10-18       Impact factor: 2.638

4.  Targeted next-generation sequencing provides novel clues for associated epilepsy and cardiac conduction disorder/SUDEP.

Authors:  Monica Coll; Pasquale Striano; Carles Ferrer-Costa; Oscar Campuzano; Jesús Matés; Bernat Del Olmo; Anna Iglesias; Alexandra Pérez-Serra; Irene Mademont; Ferran Picó; Antonio Oliva; Ramon Brugada
Journal:  PLoS One       Date:  2017-12-19       Impact factor: 3.240

Review 5.  Brain Development and Akt Signaling: the Crossroads of Signaling Pathway and Neurodevelopmental Diseases.

Authors:  Long Wang; Kai Zhou; Zhi Fu; Di Yu; Hesuyuan Huang; Xiaodong Zang; Xuming Mo
Journal:  J Mol Neurosci       Date:  2016-12-26       Impact factor: 3.444

Review 6.  mTOR signalling pathway - A root cause for idiopathic autism?

Authors:  Harsha Ganesan; Venkatesh Balasubramanian; Mahalaxmi Iyer; Anila Venugopal; Mohana Devi Subramaniam; Ssang-Goo Cho; Balachandar Vellingiri
Journal:  BMB Rep       Date:  2019-07       Impact factor: 4.778

Review 7.  Hemihydranencephaly: living with half brain dysfunction.

Authors:  Piero Pavone; Francesco Nigro; Raffaele Falsaperla; Filippo Greco; Martino Ruggieri; Renata Rizzo; Andrea D Praticò; Lorenzo Pavone
Journal:  Ital J Pediatr       Date:  2013-01-16       Impact factor: 2.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.